What this is
- How it works
- How it works isn't classified yet
- Tested for
- Atopic Dermatitis (AD) (2 trials)
- Main trialPhase 3
- “To investigate the superiority of 1% OPA-15406 foam to the vehicle in adult patients with atopic dermatitis (AD).”In the company’s words, NCT07173478 on ClinicalTrials.gov
- Other names
- difamilast
Other drugs for Atopic Dermatitis (AD)
- ICP-332Beijing InnoCare Pharma Tech Co., Ltd. · Phase 3
- UpadacitinibAbbVie · Phase 3
- MG-K10Shanghai Mabgeek Biotech.Co.Ltd · Phase 3
- GX-03Turn Therapeutics · Phase 2/3
- VC005Jiangsu vcare pharmaceutical technology co., LTD · Phase 3
- StapokibartKeymed Biosciences Co.Ltd · Phase 3
Coming up2
- DecPhase 3 trial completes · ClinicalTrials.gov
- Feb 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials9
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Not yet recruiting | Dec 2026 | A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis | |
| Phase 3Not yet recruiting | Feb 2027 | A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis | |
| Phase 3Completed | 13 Dec 2019 | Comparison Trial of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis | |
| Phase 3Completed | 28 Dec 2019 | Comparison Trial of OPA-15406 Ointment in Adult Patients With Atopic DermatitisSyndrome | |
| Phase 3Completed | 11 Nov 2020 | Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis | |
| Phase 3Completed | 29 Dec 2022 | A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis | |
| Phase 3Completed | 17 Jun 2024 | To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD | |
| Phase 3Completed | 21 Jul 2024 | To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients with AD | |
| Phase 2Completed | 28 Jan 2015 | A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026